Founders Capital Management (Texas)’s Lisata Therapeutics LSTA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.8K | Hold |
2,000
| – | – | ﹤0.01% | 309 |
|
2025
Q1 | $4.7K | Hold |
2,000
| – | – | ﹤0.01% | 310 |
|
2024
Q4 | $5.96K | Hold |
2,000
| – | – | ﹤0.01% | 300 |
|
2024
Q3 | $6K | Hold |
2,000
| – | – | ﹤0.01% | 309 |
|
2024
Q2 | $6.94K | Buy |
2,000
+1,667
| +501% | +$5.78K | ﹤0.01% | 302 |
|
2024
Q1 | $1.04K | Hold |
333
| – | – | ﹤0.01% | 336 |
|
2023
Q4 | $909 | Sell |
333
-333
| -50% | -$909 | ﹤0.01% | 363 |
|
2023
Q3 | $1.43K | Hold |
666
| – | – | ﹤0.01% | 376 |
|
2023
Q2 | $2.46K | Hold |
666
| – | – | ﹤0.01% | 356 |
|
2023
Q1 | $2K | Hold |
666
| – | – | ﹤0.01% | 364 |
|
2022
Q4 | $2K | Hold |
666
| – | – | ﹤0.01% | 358 |
|
2022
Q3 | $3K | Sell |
666
-1
| -0.1% | -$5 | ﹤0.01% | 357 |
|
2022
Q2 | $5K | Buy |
667
+334
| +100% | +$2.5K | ﹤0.01% | 367 |
|
2022
Q1 | $4K | Hold |
333
| – | – | ﹤0.01% | 292 |
|
2021
Q4 | $4K | Sell |
333
-667
| -67% | -$8.01K | ﹤0.01% | 292 |
|
2021
Q3 | $18K | Hold |
1,000
| – | – | 0.01% | 225 |
|
2021
Q2 | $24K | Buy |
+1,000
| New | +$24K | 0.02% | 186 |
|